Fig. 5From: Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysisFunnel plot of publication bias for ORR. ORR: objective response ratesBack to article page